Role of Toll-like Receptors on Human Adipose-derived Stromal Cells

¹ Department of Physiology, College of Medicine, Pusan National University, Pusan, Korea; Medical Research Institute, Pusan National University, Pusan, Korea
² Department of Plastic Surgery, College of Medicine, Pusan National University, Pusan, Korea

^* To whom correspondence should be addressed. E-mail: jsjung{at}pusan.ac.kr.

	Abstract

Backgrounds. Adult mesenchymal stem cells (MSCs) are promising tools for such applications as tissue engineering and cellular therapy. It is not clear how stem cells exposed to unfavorable conditions (eg, hypoxia or inflammation) respond to signals of danger after in vivo transplantation. Toll-like receptors (TLRs) play a major role in the immune system, participating in the initial recognition of microbial pathogens and pathogen-associated components. This study was designated to determine the role of TLRs in human MSC. Methods & Results. Reversetranscriptase polymerase chain reaction and flow cytometry analysis demonstrated that MSCs derived from human adipose tissue and bone marrow express TLR 1, 2, 3, 4, 5, 6, and 9. We investigated induction of the differentiation and proliferation of human adipose tissue stromal cells (hADSCs) by TLR agonists, including flagellin (FGN), peptidoglycans (PGN), lipopolysaccharide (LPS), the synthetic double-stranded RNA analog poly I:C, and synthetic CpG oligodeoxydinucleotide (CpG-ODN). None of these agonists, except ODN, affected the proliferation of hADSCs. LPS and PGN increased osteogenic differentiation, but CpG-ODN decreased it. Poly I:C itself did not affect adipogenic or osteogenic differentiation, but exerted a synergistic effect on LPS- or PGN-induced osteogenic differentiation. RT-PCR analysis demonstrated that LPS and PGN induce osteogenic markers in hADSCs. TLR agonists affected the expression of chemokines and cytokines differentially. Furthermore, hADSCs affected the expression of specific TLRs in vitro under hypoxic conditions. Conclusion. These data provide evidence of a nonimmune role for TLR signaling on MSCs, which may provide clues to the behavior of transplanted MSCs in vivo.

This article has been cited by other articles:

				S. L. Tomchuck, K. J. Zwezdaryk, S. B. Coffelt, R. S. Waterman, E. S. Danka, and A. B. Scandurro Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses Stem Cells, January 1, 2008; 26(1): 99 - 107. [Abstract] [Full Text] [PDF]

				F. Liotta, R. Angeli, L. Cosmi, L. Fili, C. Manuelli, F. Frosali, B. Mazzinghi, L. Maggi, A. Pasini, V. Lisi, et al. Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling Stem Cells, January 1, 2008; 26(1): 279 - 289. [Abstract] [Full Text] [PDF]

				N. Gupta, X. Su, B. Popov, J. W. Lee, V. Serikov, and M. A. Matthay Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice J. Immunol., August 1, 2007; 179(3): 1855 - 1863. [Abstract] [Full Text] [PDF]

				A. Hernando Insua, A. D. Montaner, J. M. Rodriguez, F. Elias, J. Flo, R. A. Lopez, J. Zorzopulos, E. L. Hofer, and N. A. Chasseing IMT504, the Prototype of the Immunostimulatory Oligonucleotides of the PyNTTTTGT Class, Increases the Number of Progenitors of Mesenchymal Stem Cells Both In Vitro and In Vivo: Potential Use in Tissue Repair Therapy Stem Cells, April 1, 2007; 25(4): 1047 - 1054. [Abstract] [Full Text] [PDF]

				M. Pevsner-Fischer, V. Morad, M. Cohen-Sfady, L. Rousso-Noori, A. Zanin-Zhorov, S. Cohen, I. R. Cohen, and D. Zipori Toll-like receptors and their ligands control mesenchymal stem cell functions Blood, February 15, 2007; 109(4): 1422 - 1432. [Abstract] [Full Text] [PDF]